Is CRA-032765 Safe in Breastfeeding
Question
I am a breastfeeding mother and i want to know if it is safe to use CRA-032765? Is CRA-032765 safe for nursing mother and child? Does CRA-032765 extracts into breast milk? Does CRA-032765 has any long term or short term side effects on infants? Can CRA-032765 influence milk supply or can CRA-032765 decrease milk supply in lactating mothers?
Answer by DrLact: About CRA-032765 usage in lactation
No information is available on the clinical use of CRA-032765 during breastfeeding. Because CRA-032765 is more than 97% bound to plasma proteins, the amount in milk is likely to be low. The manufacturer recommends that breastfeeding be discontinued during CRA-032765 therapy.
Alternate Drugs
Alemtuzumab(Low Risk)
Docetaxel(Dangerous)
Rituximab(Low Risk)
Dasatinib(Unsafe)
Bevacizumab(Low Risk)
Thioguanine(Dangerous)
Gemcitabine(Dangerous)
Vincristine(Dangerous)
Tamoxifen(Dangerous)
Nilotinib(Unsafe)
Mitoxantrone(Dangerous)
Mercaptopurine(Safe)
Trastuzumab(Unsafe)
Letrozole(Dangerous)
Exemestane(Dangerous)
Hydroxyurea(Low Risk)
Dactinomycin(Dangerous)
Etoposide(Dangerous)
Ipilimumab(Unsafe)
Doxorubicin(Dangerous)
Nivolumab(Unsafe)
Cladribine(Dangerous)
Pazopanib(Unsafe)
Cetuximab(Unsafe)
Cyclophosphamide(Dangerous)
Vinblastine(Dangerous)
Erlotinib(Unsafe)
Imatinib(Unsafe)
Carboplatin(Dangerous)
Cisplatin(Unsafe)
Bleomycin(Dangerous)
Paclitaxel(Dangerous)
Busulfan(Dangerous)
Vinorelbine(Dangerous)
Azelaic Acid(Safe)
Fluorouracil(Dangerous)
Dacarbazine(Dangerous)
Dasatinib(Unsafe)
Orlistat(Low Risk)
Gemcitabine(Dangerous)
Allopurinol(Safe)
Nilotinib(Unsafe)
Pazopanib(Unsafe)
Erlotinib(Unsafe)
Imatinib(Unsafe)
Nilotinib(Unsafe)
Imatinib(Unsafe)
Pazopanib(Unsafe)
Erlotinib(Unsafe)
Dasatinib(Unsafe)
Nilotinib(Unsafe)
Imatinib(Unsafe)
Pazopanib(Unsafe)
Erlotinib(Unsafe)
Dasatinib(Unsafe)